Mutant presenilin 2 causes abnormality in the brain lipid profile in the development of Alzheimer’s disease
- 1 October 2006
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 29 (10) , 884-889
Abstract
Mutation in the presenilin 2 (PS2mt) is known to be one of factors involved in the development of Alzheimer’s disease (AD). It was recently revealed that an abnormality of lipid metabolism is a phenomenon occurring in AD. Therefore, the aim of this study was to investigate the potential relationship between the mutation of PS2 and alterations of the lipid profile within the brain. The results showed there increases in the levels of cholesterol, low density lipoprotein and triglyceride, but a decrease in the level of high density lipoprotein in brain tissues expressing mutant PS2. These findings indicated that PS2mt is involved in the abnormalities of the lipid profile, which could cause or result in the development of AD.Keywords
This publication has 30 references indexed in Scilit:
- Apolipoprotein E modulates γ‐secretase cleavage of the amyloid precursor proteinJournal of Neurochemistry, 2004
- Cholesterol at the crossroads: Alzheimer's disease and lipid metabolismClinical Genetics, 2004
- Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease?Journal of Neuroscience Research, 2003
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsJournal of Cell Biology, 2003
- Alterations in behavior, amyloid p‐42, caspase‐3, and Cox‐2 in mutant PS2 transgenic mouse model of Alzheimer's diseaseThe FASEB Journal, 2002
- The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?Neuroscience Letters, 2001
- How Cells Handle CholesterolScience, 2000
- Mutant Presenilin 2 Transgenic MiceJournal of Biological Chemistry, 2000
- Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse ModelNeurobiology of Disease, 2000
- Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cellsFEBS Letters, 1996